Qiagen to Provide Technologies for Blood Screening Program in Brazil | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen today said that it will provide molecular sample and assay technologies for a PCR-based blood screening program for HIV and hepatitis C virus in Brazil.

The contract — signed with Bio-Manguinhos, which provides vaccines and diagnostics to the Brazilian Ministry of Health — will run for five years, following approval by Brazilian patent authorities. The deal contains options for subsequent extensions, said Qiagen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.